GGQPX
Price
$23.61
Change
+$0.34 (+1.46%)
Updated
Jul 3 closing price
Net Assets
1.03B
PAMCX
Price
$96.01
Change
+$0.40 (+0.42%)
Updated
Jul 3 closing price
Net Assets
28B
Interact to see
Advertisement

GGQPX vs PAMCX

Header iconGGQPX vs PAMCX Comparison
Open Charts GGQPX vs PAMCXBanner chart's image
Goldman Sachs Mid Cap Growth P
Price$23.61
Change+$0.34 (+1.46%)
VolumeN/A
Net Assets1.03B
T. Rowe Price Mid-Cap Growth Adv
Price$96.01
Change+$0.40 (+0.42%)
VolumeN/A
Net Assets28B
GGQPX vs PAMCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GGQPX vs. PAMCX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGQPX is a StrongBuy and PAMCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 28B vs. GGQPX (1.03B). GGQPX (0.00) and PAMCX (0.00) have matching dividends . GGQPX was incepted earlier than PAMCX: GGQPX (7 years) vs PAMCX (25 years). PAMCX (1.01) and GGQPX (1.00) have similar cost to investors . GGQPX is a more actively managed with annual turnover of: 63.00 vs. PAMCX (22.60). GGQPX has a lower initial minimum investment than PAMCX: GGQPX (0) vs PAMCX (2500). GGQPX annual gain was more profitable for investors over the last year : 18.35 vs. PAMCX (-2.05). GGQPX return over 5 years is better than : 10.12 vs. PAMCX (5.54).
GGQPXPAMCXGGQPX / PAMCX
Total Expense Ratio0.851.0184%
Annual Report Gross Expense Ratio1.001.0199%
Fund Existence7 years25 years-
Gain YTD10.7932.182495%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.03B28B4%
Annual Yield % from dividends0.000.00-
Returns for 1 year18.35-2.05-895%
Returns for 3 years47.8413.70349%
Returns for 5 years10.125.54183%
Returns for 10 yearsN/A20.74-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GANX1.690.06
+3.36%
Gain Therapeutics
AVDL8.930.12
+1.36%
Avadel Pharmaceuticals plc
ENSG150.181.27
+0.86%
Ensign Group (The)
STEM7.52N/A
N/A
Stem Inc
PNFPP24.20-0.05
-0.21%
Pinnacle Financial Partners